510(k) Report

510(k) · Cleared

Cleared

Riptide Aspiration System

K201689510(k) SpecialCleared Jul 21, 202029-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · NRY Catheter, Thrombus Retriever

Cleared on Jul 21, 2020 as substantially equivalent to K172448 (Micro Therapeutics, Inc. d/b/a ev3 Neurovascular, 2017) after a 29-day review. Its family tree reaches back 10 generations to 2001. 1 later device descends from it.

Decided
Jul 21, 2020
Review
29 days
Class
Class II
Product code
NRY
Recalls
None
Predicates
1

Its longest line of descent runs back 10 generations to K003410 (2001). 14 ancestors in all, the oldest K003086 (2001). 1 later device descends from it, 1 citing it directly.

  1. Root · 10 generations backK003410 Concentric Retriever, Model 90030Concentric Medical, Inc. · 2001 · Recalled
  2. 6 generations between
  3. 3 generations backK152541 Penumbra System ACE 64 and ACE 68 Reperfusion CathetersPenumbra, Inc. · 2016
  4. 2 generations backK160449 Penumbra System, Penumbra Pump MAXPenumbra, Inc. · 2016
  5. 1 generation backK172448 Riptide Aspiration SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 2017
  6. This deviceK201689 Riptide Aspiration SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 2020
  7. Descendant · cites it directly · 0 of its ownK243080 Riptide Aspiration SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 2024
Show all 10 generations
  1. Root · 10 generations backK003410 Concentric Retriever, Model 90030Concentric Medical, Inc. · 2001 · Recalled
  2. 9 generations backK030476 Modified Concentric Retriever, Model 90037Concentric Medical, Inc. · 2003 · Recalled
  3. 8 generations backK033736 Merci Retriever, Models 90065, 90066Concentric Medical, Inc. · 2004
  4. 7 generations backK072718 Penumbra SystemPenumbra, Inc. · 2007 · Recalled
  5. 6 generations backK100769 Penumbra System Separator Flex (026,032,041,054), Models PSF026…Penumbra, Inc. · 2010
  6. 5 generations backK113163 Penumbra System MaxPenumbra, Inc. · 2011
  7. 4 generations backK142458 Penumbra System ACEPenumbra, Inc. · 2015
  8. 3 generations backK152541 Penumbra System ACE 64 and ACE 68 Reperfusion CathetersPenumbra, Inc. · 2016
  9. 2 generations backK160449 Penumbra System, Penumbra Pump MAXPenumbra, Inc. · 2016
  10. 1 generation backK172448 Riptide Aspiration SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 2017
  11. This deviceK201689 Riptide Aspiration SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 2020

Most influential descendants

Showing 1 of 1 · See all
  • K243080Riptide Aspiration SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 2024 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−10K003410Concentric Retriever, Model 90030Concentric Medical, Inc.20011
−9K030476Modified Concentric Retriever, Model 90037Concentric Medical, Inc.20032
−8K033736Merci Retriever, Models 90065, 90066Concentric Medical, Inc.2004—
−7K072718Penumbra SystemPenumbra, Inc.20071
−6K100769Penumbra System Separator Flex (026,032,041,054), Models PSF026, PSF032…Penumbra, Inc.2010—
−5K113163Penumbra System MaxPenumbra, Inc.2011—
−4K142458Penumbra System ACEPenumbra, Inc.2015—
−3K152541Penumbra System ACE 64 and ACE 68 Reperfusion CathetersPenumbra, Inc.2016—
−2K160449Penumbra System, Penumbra Pump MAXPenumbra, Inc.2016—
−1K172448Riptide Aspiration SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular2017—
0 (this device)K201689Riptide Aspiration SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular2020—
+1K243080Riptide Aspiration SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
200910
201210
201410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202410
FIG. 1 — Lineage of K201689, 2001–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NRY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NRY device

  1. #1 K232971 APRO 55 Catheter and Alembic Aspiration Tubingscore 18.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K172448Riptide Aspiration System
Summary page 4
…Device Classification Class II Riptide™ Aspiration System Predicate Device: 510(k): K172448 Device Description: The Riptide™ Aspiration System is composed of the following components: 1. React™ Catheters 2.…
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2017—

Also cleared against K172448: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K243080Riptide Aspiration SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular20240

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 3 companies; a new generation was cleared every 1.8 years on median.
  • 3 of the 14 ancestors have a recall of any class.
  • Of its descendants, K243080 (Micro Therapeutics, Inc. d/b/a ev3 Neurovascular, 2024) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K172448.

How does its category compare?

All NRY devices

NRY Catheter, Thrombus Retriever: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · NRY

15in 2025

2007: 52008: 22009: 22010: 12011: 22012: 42014: 42015: 62016: 52017: 32018: 112019: 72020: 62021: 92022: 32023: 82024: 82025: 152026 (partial year): 14
2007high 15 (2025) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NRY

129in 2025

2007: 94 days median2012: 90 days median2014: 140 days median2015: 128 days median2016: 75 days median2017: 185 days median2018: 156 days median2019: 89 days median2020: 125 days median2021: 80 days median2022: 129 days median2023: 112 days median2024: 165 days median2025: 129 days median2026 (partial year): 147 days median
2007high 185 (2017) · low 75 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NRY

4in 2020

2010: 12013: 12017: 42020: 4, 4 Class I2026 (partial year): 2
2007high 4 (2017) · low 0 (2007)2026

Class I (4 since 2007) Class II/III not classified

Adverse event reports per year · NRY

565in 2025

2007: 132008: 182009: 572010: 2892011: 2632012: 3662013: 4052014: 4282015: 5982016: 4972017: 4322018: 4152019: 6502020: 7032021: 6882022: 5492023: 7112024: 6412025: 565
2007high 711 (2023) · low 13 (2007)2025

MAUDE reports naming product code NRY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007594013
20082—018
20092—057
20101—1289
20112—0263
20124900366
20130—1405
201441400428
201561280598
20165750497
201731854432
2018111560415
20197890650
202061254 (4)703
20219800688
202231290549
202381120711
202481650641
2025151290565
2026141472—

What is it indicated for?

The Riptide™ Aspiration System is intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K201689: Riptide Aspiration System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K201689

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026